Biostar Pharmaceuticals, Inc. announced unaudited consolidated earnings results of the second quarter and six months ended June 30, 2015. For the quarter, the company reported sales, net of $14,176,234 against $19,198,854 a year ago. Loss from operations was $1,073,184 against $1,963,182 a year ago. Loss before income taxes was $661,499 against income before income taxes of $1,178,845 a year ago. Net loss was $492,427 or $0.03 per basic and diluted share against net income of $1,645,494 or $0.11 per basic and diluted share a year ago.

For the six months, the company's sales, net were $21,084,981 against $32,380,018 a year ago. Loss from operations was $1,963,182 against $307,764 a year ago. Loss before income taxes was $1,300,474 against income before income tax of $1,784,756 a year ago. Net loss was $652,531 or $0.04 per basic and diluted share against net income of $1,952,164 or $0.14 per basic and diluted share a year ago. Net cash provided by operating activities was $439,558 against $1,036,577 a year ago. Purchase of property and equipment was $30,760 against $479,792 a year ago.